sam patrick posted an article7 years in a row for MUSC see more
MUSC Health University Medical Center in Charleston was named by U.S. News & World Report for the seventh year in a row as the No. 1 hospital in South Carolina, with three of MUSC Health’s specialty areas ranking among the best in the entire country: ear, nose and throat; gynecology and cancer.
Seventeen other MUSC Health programs are considered “high performing” specialties, procedures or conditions in the 2021-2022 U.S. News & World Report rankings: gastroenterology and GI surgery, abdominal aortic aneurysm repair, aortic valve surgery, heart attack, heart bypass surgery, heart failure, back surgery (spinal fusion), hip replacement, kidney failure, chronic obstructive pulmonary disease (COPD), lung cancer surgery, pneumonia, stroke, colon cancer surgery, rheumatology, orthopedics and urology.
In addition, MUSC Health Florence Medical Center is designated as “high performing” in chronic obstructive pulmonary disease (COPD), heart failure, heart attack and kidney failure.
“Once again, South Carolinians can take great pride and comfort in the knowledge that their only public, statewide hospital system is consistently cited as one of the best in the country,” said Patrick J. Cawley, M.D., MUSC Health CEO and MUSC vice president for Health Affairs, University. “It’s a transformational time in health care and these rankings are a testament to our care team’s commitment to ensure that our patients are receiving the right care, in the right place and at the right time. The achievements in our Charleston and Florence divisions made despite the pandemic should remind us all what’s possible through innovation, teamwork, and growth.”
U.S. News & World Report unveiled the 32th edition of the Best Hospitals rankings at https://health.usnews.com/best-hospitals/rankings. Designed to help patients with life-threatening or rare conditions identify hospitals that excel in treating the most difficult cases, Best Hospitals 2021-22 includes consumer-friendly data and information on 4,750 medical centers nationwide in 15 specialties and 17 procedures and conditions. In the 15 specialty areas, 175 hospitals were ranked in at least one specialty. In rankings by state and metro area, U.S. News & World Report recognized hospitals as high performing across multiple areas of care.
“I am so proud that U.S. News & World Report has recognized MUSC Health Florence Medical Center as high performing in four areas – chronic obstructive pulmonary disease (COPD), heart failure, heart attack and kidney failure,” said Jay Hinesley, MUSC Health Florence Division CEO. “The last year has been a challenge for everyone in health care, and these recognitions are a true testament to all the hard work of our care team members and their dedication to our patients, families and communities. We are committed to continuing to preserve and optimize human life in South Carolina and beyond.”
The U.S. News & World Report Best Hospitals methodologies, in most areas of care, are based largely or entirely on objective measures such as risk-adjusted survival and readmission rates, volume, patient experience, patient safety and quality of nursing, among other care-related indicators.
1. - U.S. News & World Report’s produced Best Hospitals with RTI International, a leading research organization based in Research Triangle Park, N.C.
sam patrick posted an articleMultimillion-dollar grant to support heart health research at Clemson University see more
Clemson University bioengineers picked Valentine’s Day to announce $4.1 million in grants to support new heart health research.
Will Richardson and Naren Vyavahare are conducting research with the potential to affect millions of patients who suffer from many forms of cardiovascular disease and related illness, including heart failure, hypertension, chronic kidney disease and Type 2 diabetes, according to a university news release.
Richardson, an assistant professor of bioengineering, is creating computer models aimed at providing better treatment for cardiac fibrosis, a condition that contributes to heart failure. As many as 60% of patients die within five years of developing heart failure, which afflicts 6.5 million Americans, Richardson said in the news release.
No drugs have been approved to treat cardiac fibrosis specifically, and doctors are often left with trial-and-error experimentation when treating patients who have it, he said in the release.
Richardson said he hopes his research will lead to a day when measurements from a patient’s blood or tissue sample can be plugged into mathematical equations based on how molecules interact in the body. Overnight, patients would have personalized risk assessments and treatments plan, he said in the release.
Details about his research is available online.
Vyavahare, the Hunter Endowed Chair of Bioengineering, is working on what could be the first treatment to reverse vascular calcification, a condition that occurs when mineral deposits build up on blood vessel walls and stiffen them, according to the news release. It is most prevalent in aging patients and those with chronic kidney disease and Type 2 diabetes, Vyavahare said. Complications from vascular calcification can range from hypertension to death.
The nanoparticles that Vyavahare is developing are many times smaller than the width of a human hair and would deliver two medicines to calcified blood vessels. One medicine would remove the mineral deposits that cause blood vessels to become calcified, and another would return elasticity to the blood vessels.
More details about his work is online.
The Richardson and Vyavahare projects were both funded through the National Institutes of Health’s R01 program. Richardson is receiving $1.9 million, and Vyavahare is receiving $2.2 million, the news release said.
Anand Gramopadhye, dean of the College of Engineering, Computing and Applied Sciences, congratulated Richardson and Vyvahare on their grants.
Agneta Simionescu, an assistant professor of bioengineering, has also received $1.38 million through the R01 program. The Simionescu award was announced in November and is aimed at better understanding cardiovascular disease in patients with diabetes, the news release said.
Richardson and Simionescu were among the faculty members trained as part of SC BioCRAFT, a National Institutes of Health Center of Excellence. The center’s primary goal is to increase the number of South Carolina biomedical researchers who are supported by grants from the National Institutes of Health.
Vyavahare leads SC BioCRAFT, which stands for the South Carolina Bioengineering Center for Regeneration and Formation of Tissues.